Zevra Therapeutics Announces Inducement Grants under Nasdaq

CELEBRATION, Fla., Oct. 06, 2025 (GLOBE NEWSWIRE) — Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announced that the Company has granted options to purchase an aggregate of 38,000 shares of the Company’s common stock (the “Inducement Awards”) to two … Read more

PrairieSky Royalty Announces Conference Call for Q3 2025

CALGARY, Alberta, Oct. 06, 2025 (GLOBE NEWSWIRE) — PrairieSky will release its Q3 2025 results on Monday, October 20, 2025 after markets close. The news release detailing PrairieSky’s Q3 2025 results will provide operating and financial information. Financial statements along with management’s discussion and analysis will be available on PrairieSky’s website at www.prairiesky.com and on SEDAR+ … Read more

Dyne Therapeutics Announces Additional One-Year Clinical

– Robust improvement demonstrated across diverse set of clinical measures – – Patient-reported outcomes support clinical meaningfulness of improvements in function and strength – – Meaningful improvements in overall disease burden reported by both patients and physicians – WALTHAM, Mass., Oct. 06, 2025 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused … Read more

Ryoncil® Revenues Increase 66% in Second Quarter Post

NEW YORK, Oct. 06, 2025 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced gross revenue of US$21.9 million on Ryoncil® (remestemcel-L-rknd) sales for the quarter ended September 30, 2025. This represents a 66% increase on the prior quarter ended June 30, 2025, with similar gross … Read more

Eagle Pharmaceuticals Announces Availability of Unaudited

WOODCLIFF LAKE, N.J., Oct. 06, 2025 (GLOBE NEWSWIRE) — Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that the Company’s unaudited financial statements for the three months ended March 31, 2025, are available at https://investor.eagleus.com/events-presentations. About Eagle Pharmaceuticals, Inc. Eagle is a fully integrated pharmaceutical company with research and development, clinical, manufacturing and … Read more

Verde AgriTech Announces District Scale

SINGAPORE, Oct. 06, 2025 (GLOBE NEWSWIRE) — In a release issued under the same headline earlier today by Verde AgriTech Ltd. (TSX: NPK | OTCQX: VNPKF), please note: we updated the Appendix table to correct a presentation alignment. The column headings list the individual oxides in alphabetical order, followed by TREO and MREO; the data … Read more